Concepedia

Adam Janik

AJ

Statistics

Publications

7

Citations

1.2K

H-Index

7

Active since

2013

Affiliations

Janssen (United States)(Current)

University of Pennsylvania

Janssen (Belgium)

University of Alabama at Birmingham

Janssen (France)

Adam Janik is an author at Janssen (United States) specializing in pharmacy, pharmacotherapy, and psychopharmacology.

Publications per year

2013–2025

7

Publications

7

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Ella Daly, Madhukar H. Trivedi, Adam Janik et al. · JAMA Psychiatry · 2019 · 759 citations · Full text

, , +17

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Adam Savitz, Haiyan Xu, Srihari Gopal et al. · The International Journal of Neuropsychopharmacology · 2016 · 162 citations · Full text

, , +16

Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

A. Schreiner, Kaire Aadamsoo, A.C. Altamura et al. · Schizophrenia Research · 2015 · 143 citations · Full text

, , +17

Esketamine Monotherapy in Adults With Treatment-Resistant Depression

Adam Janik, Xin Qiu, Rosanne Lane et al. · JAMA Psychiatry · 2025 · 36 citations · Full text

, , +17

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies

Richard L. Doty, Vanina Popova, Crystal Wylie et al. · CNS Drugs · 2021 · 23 citations · Full text

, , +17

1–5 of 7